| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $49.4M | -18.9% |
| SG&A Expense | $33.6M | -9.7% |
| Operating Income | -$83.0M | +1.2% |
| Interest Expense | $961K | +25.8% |
| Pre-tax Income | -$81.6M | +3.6% |
| Income Tax | -$2K | -113.3% |
| Net Income | -$81.6M | +3.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $52.0M | -34.8% |
| Current Assets | $87.5M | -35.1% |
| Total Assets | $121.2M | -34.6% |
| Current Liabilities | $21.0M | +84.0% |
| Total Liabilities | $52.0M | -4.6% |
| Stockholders' Equity | $69.2M | -47.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$58.2M | +23.4% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $31.1M | +147.1% |
| Financing Cash Flow | -$577K | -142.5% |
| Free Cash Flow | -$58.2M | +26.3% |